A study in healthy people to test how well different doses of BI 3000202 are tolerated and how they affect the way the body handles midazolam

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-509293-29-00

Acronym

1509-0002

Enrollment

Registered

2024-03-18

Start date

2024-03-28

Completion date

2024-09-27

Last updated

2024-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer trial

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026